Novel Micellar Formulation of Silymarin (Milk Thistle) with Enhanced Bioavailability in a Double-Blind, Randomized, Crossover Human Trial

Chuck Chang, Yiming Zhang, Yun Chai Kuo, Min Du, Kyle Roh, Roland Gahler, Afoke Ibi, Julia Solnier

Open source

DOI
10.3390/pharmaceutics17070880
Published
2025-07-04
Container
Pharmaceutics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics17070880,
  title = {Novel Micellar Formulation of Silymarin (Milk Thistle) with Enhanced Bioavailability in a Double-Blind, Randomized, Crossover Human Trial},
  author = {Chuck Chang and Yiming Zhang and Yun Chai Kuo and Min Du and Kyle Roh and Roland Gahler and Afoke Ibi and Julia Solnier},
  year = {2025},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics17070880},
  url = {https://doi.org/10.3390/pharmaceutics17070880}
}

RIS

TY  - JOUR
TI  - Novel Micellar Formulation of Silymarin (Milk Thistle) with Enhanced Bioavailability in a Double-Blind, Randomized, Crossover Human Trial
AU  - Chuck Chang
AU  - Yiming Zhang
AU  - Yun Chai Kuo
AU  - Min Du
AU  - Kyle Roh
AU  - Roland Gahler
AU  - Afoke Ibi
AU  - Julia Solnier
PY  - 2025
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics17070880
UR  - https://doi.org/10.3390/pharmaceutics17070880
ER  - 

APA

Chang, C., Zhang, Y., Kuo, Y. C., Du, M., Roh, K., Gahler, R., Ibi, A., & Solnier, J. (2025). Novel Micellar Formulation of Silymarin (Milk Thistle) with Enhanced Bioavailability in a Double-Blind, Randomized, Crossover Human Trial. Pharmaceutics. https://doi.org/10.3390/pharmaceutics17070880

Source records